MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
38 hedge funds and large institutions have $28M invested in Merrimack Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Holders
38
Holding in Top 10
1
Calls
$801K
Puts
$281K
Top Buyers
| 1 | +$2.05M | |
| 2 | +$776K | |
| 3 | +$387K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$124K |
| 5 |
LA
LVW Advisors
Pittsford,
New York
|
+$80K |
Top Sellers
| 1 | -$81K | |
| 2 | -$63K | |
| 3 | -$25K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$20.5K |
| 5 |
WR
Watson Rebecca
|
-$10K |